search
Back to results

Identification of Vulnerability Factors in the Course of Pemphigus Patients (SHS-Pemphigus)

Primary Purpose

Pemphigus, Dermatological Disease

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
psychological support and therapeutic education program
Sponsored by
University Hospital, Rouen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Pemphigus focused on measuring psychological support, therapeutic education, vulnerability of patients

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient major
  • Patients with pemphigus vulgaris, diagnosed on a combination of:

    1. clinical signs and
    2. histological image above basal epithelial detachment with intra acantholysis,
    3. direct immunofluorescence showing deposition of Immunoglobulin G and / or C3 to the surface of keratinocytes
  • Join a social security scheme
  • patient has been informed and have signed consent to participate in the study

Exclusion Criteria:

  • Person placed under judicial protection,
  • Patient without liberty by administrative or judicial decision,
  • Patient participating in another trial for the duration of monitoring.

Sites / Locations

  • Hôpital AvicenneRecruiting
  • CHU de Clermont-Ferrand Hôpital d'EstaingRecruiting
  • CH du MansRecruiting
  • CHRU de Lille Hôpital Claude HuriezRecruiting
  • Hôpital La Timone, Assistance publique hôpitaux de Marseille-AixRecruiting
  • Hôpital Haut-LévêqueRecruiting
  • Centre hospitalier de CornouailleRecruiting
  • Hôpital Robert Debré, chu de ReimsRecruiting
  • University Hospital of RouenRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

prevalent cases

Arm Description

40 prevalent cases correspond to patients with known pemphigus. Emphasis will be on included patients at different times of the course of their disease. 8 incident cases recruited through the center of Rouen and following an intervention program with psychological support and therapeutic education program

Outcomes

Primary Outcome Measures

analysis of vulnerability factors
evaluation of : perception by the patient of misdiagnosis, perception of a possible difference in assessment of the severity of his illness between himself and healthcare professionals, patient behavior in relation to available information sources, and the influence of information gathered on the illness experience, Patient trajectory during the diagnostic phase using individual interview and questionnaire

Secondary Outcome Measures

analysis of vulnerability factors
evaluation of : perception by the patient of misdiagnosis, perception of a possible difference in assessment of the severity of his illness between himself and healthcare professionals, patient behavior in relation to available information sources, and the influence of information gathered on the illness experience, Patient trajectory during the diagnostic phase using individual interview and questionnaire
assessment of anxiety, uncertainty, fear, coping strategies
assessment of anxiety, uncertainty, fear, coping strategies using individual interview and questionnaire
assessment of anxiety, uncertainty, fear, coping strategies
assessment of anxiety, uncertainty, fear, coping strategies using individual interview and questionnaire

Full Information

First Posted
September 1, 2014
Last Updated
August 29, 2017
Sponsor
University Hospital, Rouen
search

1. Study Identification

Unique Protocol Identification Number
NCT02237313
Brief Title
Identification of Vulnerability Factors in the Course of Pemphigus Patients
Acronym
SHS-Pemphigus
Official Title
Identification of Vulnerability Factors in the Course of Pemphigus Patients - SHS Pemphigus Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Unknown status
Study Start Date
July 2015 (undefined)
Primary Completion Date
May 2018 (Anticipated)
Study Completion Date
November 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Rouen

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The bullous pemphigoid treatment is based on corticosteroids continued for several years. Pemphigus causes some patients a psychological impact and sometimes major vulnerability that can occur not only at diagnosis but also at later stages of disease progression. Our hypothesis is that these episodes of vulnerability may be under four kinds of factors that may be connected to the plurality of the history of these patients, and the resources they can mobilize throughout this experience, generating inequality in management and "work" around the disease.
Detailed Description
The originality of the project lies in its multidisciplinary approach (dermatology, psychology, sociology). No such study has yet been carried out in the pemphigus who has been the subject of a very small number of works in sociology or psychology. The only studies are studies of quality of life with no longitudinal follow-up. The perspective of qualitative and quantitative data, sociological and psychological approaches, should allow more innovative and adapted to the medico-social and psychological care of patients with pemphigus approaches. The purpose of this study is to identify the determinants leading to moments of vulnerability in the course of patients with pemphigus in order to be able to offer preventive or corrective actions to improve the experience of the disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pemphigus, Dermatological Disease
Keywords
psychological support, therapeutic education, vulnerability of patients

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
prevalent cases
Arm Type
Experimental
Arm Description
40 prevalent cases correspond to patients with known pemphigus. Emphasis will be on included patients at different times of the course of their disease. 8 incident cases recruited through the center of Rouen and following an intervention program with psychological support and therapeutic education program
Intervention Type
Behavioral
Intervention Name(s)
psychological support and therapeutic education program
Primary Outcome Measure Information:
Title
analysis of vulnerability factors
Description
evaluation of : perception by the patient of misdiagnosis, perception of a possible difference in assessment of the severity of his illness between himself and healthcare professionals, patient behavior in relation to available information sources, and the influence of information gathered on the illness experience, Patient trajectory during the diagnostic phase using individual interview and questionnaire
Time Frame
12 months
Secondary Outcome Measure Information:
Title
analysis of vulnerability factors
Description
evaluation of : perception by the patient of misdiagnosis, perception of a possible difference in assessment of the severity of his illness between himself and healthcare professionals, patient behavior in relation to available information sources, and the influence of information gathered on the illness experience, Patient trajectory during the diagnostic phase using individual interview and questionnaire
Time Frame
6 months
Title
assessment of anxiety, uncertainty, fear, coping strategies
Description
assessment of anxiety, uncertainty, fear, coping strategies using individual interview and questionnaire
Time Frame
12 months
Title
assessment of anxiety, uncertainty, fear, coping strategies
Description
assessment of anxiety, uncertainty, fear, coping strategies using individual interview and questionnaire
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient major Patients with pemphigus vulgaris, diagnosed on a combination of: clinical signs and histological image above basal epithelial detachment with intra acantholysis, direct immunofluorescence showing deposition of Immunoglobulin G and / or C3 to the surface of keratinocytes Join a social security scheme patient has been informed and have signed consent to participate in the study Exclusion Criteria: Person placed under judicial protection, Patient without liberty by administrative or judicial decision, Patient participating in another trial for the duration of monitoring.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pascal JOLY, Professor
Phone
2 32 88 68 41
Ext
+33
Email
pacal.joly@chu-rouen.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pascal Joly, Professor
Organizational Affiliation
University Hospital, Rouen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Avicenne
City
Bobigny
ZIP/Postal Code
93000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Catherine PROST-SQUARCIONI, Professor
Phone
1 48 95 77 07
Ext
+33
Email
catherine.prost@avc.aphp.fr
First Name & Middle Initial & Last Name & Degree
Catherine PROST-SQUARCIONI, professor
Facility Name
CHU de Clermont-Ferrand Hôpital d'Estaing
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michel D'Incan, professor
Phone
4 73 75 05 50
Ext
+33
Email
mdincan@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Michel D'Incan, Professor
Facility Name
CH du Mans
City
le Mans
ZIP/Postal Code
72037
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hervé MAILLARD, Professor
Phone
2 43 43 43 58
Ext
+33
Email
hmaillard@ch-lemans.fr
First Name & Middle Initial & Last Name & Degree
Hervé MAILLARD, Professor
Facility Name
CHRU de Lille Hôpital Claude Huriez
City
Lille
ZIP/Postal Code
59037
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emmanuel DELAPORTE, Professor
Phone
3 20 44 41 91
Ext
+33
Email
Emmanuel.Delaporte@chru-lille.fr
First Name & Middle Initial & Last Name & Degree
Emmanuel DELAPORTE, Professor
Facility Name
Hôpital La Timone, Assistance publique hôpitaux de Marseille-Aix
City
Marseille
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marie-Aleth RICHARD LALLEMAND, Professor
Phone
4 91 38 79 91
Ext
+33
Email
mrichard@ap-hm.fr
First Name & Middle Initial & Last Name & Degree
Marie Alteh RICHARD LALLEMAND, Professor
Facility Name
Hôpital Haut-Lévêque
City
Pessac
ZIP/Postal Code
33604
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marie Sylvie DOUTRE, Professor
Email
marie-sylvie.doutre@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Marie Sylvie DOUTRE, Professor
Facility Name
Centre hospitalier de Cornouaille
City
Quimper
ZIP/Postal Code
29107
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ingrid KUPFER-BESSAGUET, Doctor
Phone
2 98 52 60 60
Ext
+33
Email
i.kupfer@ch-cornouaille.fr
First Name & Middle Initial & Last Name & Degree
Ingrid KUPFER-BESSAGUET, Doctor
Facility Name
Hôpital Robert Debré, chu de Reims
City
Reims
ZIP/Postal Code
51 092
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Philippe BERNARD, Professor
Phone
3 26 78 43 68
Ext
+33
Email
pbernard@chu-reims.fr
First Name & Middle Initial & Last Name & Degree
Philippe BERNARD, Professor
Facility Name
University Hospital of Rouen
City
Rouen
ZIP/Postal Code
76031
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pascal JOLY, Professor
Phone
2 32 88 80 39
Ext
+33
Email
Pascal.Joly@chu-rouen.fr
First Name & Middle Initial & Last Name & Degree
Sophie DUVERT LEHEMBRE, Doctor

12. IPD Sharing Statement

Learn more about this trial

Identification of Vulnerability Factors in the Course of Pemphigus Patients

We'll reach out to this number within 24 hrs